Cannabis Suisse Corp. (CSUI) intrinsic value & 10-year financials
Cannabis Suisse Corp. (CSUI) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 10 fiscal years revenue grew 5.9% a year to $22.5K, with an average return on invested capital of -247.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.01
- Market cap
- $400.2K
- Revenue (FY2025)
- $22.5K
- Revenue growth (10-yr CAGR)
- 5.9%
- ROIC (10-yr avg)
- -247.8%
- Free cash flow (FY2025)
- —
CSUI 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $22.5K | -$456.1K | — | — | -1280.1% | 26.4% |
| FY2024 | $30.0K | -$1.3M | — | — | -856.5% | 46.3% |
| FY2023 | $10.0K | -$351.5K | — | — | -3426.8% | 172.7% |
| FY2022 | $7.8K | -$187.9K | — | — | -2022.6% | 57.3% |
| FY2021 | $50.9K | -$419.4K | — | — | -704.9% | 93.6% |
| FY2020 | $242.7K | -$389.2K | — | — | -144.7% | 101.7% |
| FY2019 | $7.5K | -$22.7K | — | — | -301.8% | -360.5% |
| FY2018 | $6.5K | -$16.4K | — | — | -252.6% | -1867.1% |
| FY2017 | $14.2K | -$26.7K | — | — | -187.9% | -500.6% |
| FY2016 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
CANNABIS SUISSE CORP. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
CANNABIS SUISSE CORP. has earned high returns on invested capital, averaging 33.3% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
CANNABIS SUISSE CORP. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, CANNABIS SUISSE CORP. is modeled at 5.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-0.15 per share.